MetaCap

SkinHealth Systems (SKIN) vs Neuronetics (STIM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SkinHealth Systems (SKIN) has outperformed Neuronetics (STIM) over the past year, gaining 791.7% versus a loss of 4.6%. Over five years, SKIN leads with a -57.1% price change compared with -69.7% for STIM. Neuronetics is the larger company by market cap ($120.6 million vs $76.7 million), about 1.6 times the size.

SkinHealth Systems converts more of its revenue into profit, with a net margin of -3.2% versus -26.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SKIN+791.67%STIM-4.58%
+1231%+557%-117%
Nov 21, 20251 yearNov 20, 2026
SKIN-59.10%STIM-68.75%
+80%-13%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SKIN versus STIM key metrics
MetricSKINSTIM
Share price$11.77$1.25
Market cap$76.68M$120.60M
1-day change-3.13%+0.81%
YTD return+746.76%-9.42%
1-year return+791.67%-4.58%
5-year return-57.11%-69.66%
Forward P/E2.63—
EPS (TTM)$-2.98$-0.32
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$300.79M$149.16M
Revenue growth (YoY)-10.02%+99.17%
Net income (latest FY)$-9.52M$-39.00M
Gross margin65.28%48.48%
Operating margin-6.92%-21.08%
Net margin-3.16%-26.15%
52-week high$33.00$3.44
52-week low$9.68$0.80
Distance from 52-week high-64.33%-63.66%
Analyst consensusholdstrong_buy
Avg. price target upside+24.64%+380.00%
Average volume43.46K1.76M
Shares outstanding6.51M96.48M
Employees613658
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SKIN has outperformed STIM by 796.2 percentage points over the past year.
  • SkinHealth Systems is more profitable, keeping -3.2 cents of every revenue dollar as net income versus -26.1 cents for Neuronetics.
  • Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs -10.02%).

About SkinHealth Systems

SKIN stock →

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.

Health Care · Medical/Dental Instruments · 613 employees

About Neuronetics

STIM stock →

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

Health Care · Medical/Dental Instruments · 658 employees

SKIN vs STIM FAQ

Which is bigger, SkinHealth Systems or Neuronetics?

Neuronetics (STIM) is larger, with a market capitalization of $120.60M compared with $76.68M for SkinHealth Systems (SKIN).

Which stock has performed better over the past year, SKIN or STIM?

SKIN returned +791.67% over the past 12 months, compared with -4.58% for STIM (price return, excluding dividends). Past performance does not predict future results.

Are SkinHealth Systems and Neuronetics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons